Fernando Pacheco
Investment Director @ Endeavour Vision
Geneva, Switzerland
Fernando Pacheco is a startup investor at Endeavour Vision in Geneva. Fernando joined Endeavour Vision in 2018 and currently serves as an investment manager, focusing on medical technology and digital health investments.Fernando brings medical device industry expertise in product development, combined with pharmaceutical and medical device business and strategy consulting. From 2011 to 2015, Fernando led thedevelopment of a number of orthopaedic trauma solutions at Stryker Orthopaedics R&D in Switzerland – focusing on upper trauma and extremities. From 2015 to 2018, Fernando was Engagement Manager at McKinsey & Company in Geneva, Switzerland. He led a number of business strategy and organisational projects including therapeutic-area strategy, merger management, process optimization, operating model re-design, corporate due-diligence and market access and launch preparation. Fernando worked across a number of geographies, including Switzerland, France, Germany, Belgium, UK, US and Brazil and sectors such as diabetes, specialty pharmaceuticals, infectious disease, wound care, surgical instruments, orthopaedics and dental.Fernando holds an MEng degree in Biomedical and Mechanical Engineering from Imperial College London and the Swiss Federal Institute of Technology (ETH) Zürich. His Masters’ thesis was in cardiovascular fluid mechanics of stented arteries. Fernando is fluent in English, Portuguese, Spanish, French and German. Fernando is a Brazilian and Portuguese citizen and has lived in Brazil, Portugal, the UK and, for the past 8 years, Switzerland. He is married and enjoys spending time with his wife, running, playing basketball and tennis and practicing Nordic and downhill skiing.
Last updated:
For AI agents: llms.txt
About Endeavour Vision
Endeavour Vision is a private equity firm investing in growth-stage MedTech and digital health companies. The company invests in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Endeavour Vision team offers strategic and operational expertise and extensive internationalexperience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.
Endeavour Vision Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Schmitz
Partner
|
|||
Bernard Vogel
Founder and Managing Partner
|
|||
Damien Tappy
President & Managing Partner
|
|||
Daniel van den Bergh
Senior Investment Director
|
|||
|
Fernando Pacheco
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
